Bill > HB2267

This bill amends the Public School Code of 1949 to allow students with pancreatic insufficiency or cystic fibrosis to possess and self-administer prescribed pancreatic enzyme replacement therapy (PERT) in school settings. PERT is a supplement used to treat malabsorption syndrome caused by pancreatic problems, often associated with cystic fibrosis. To be eligible, students must provide a doctor's order detailing the medication, dosage, and need, along with a parent's request for the school to follow the doctor's instructions and a statement releasing the school from responsibility for the student taking the medication. The student must also demonstrate competency in self-administration and understand safety precautions. Schools will be required to develop policies outlining the process for submitting documentation, where PERT can be stored if not self-carried (limited to a daily supply), and that any excess must be kept in the school nurse's office or a designated location. If a student is not permitted to self-administer PERT, it must be stored in an accessible location, and relevant school staff must be informed. The bill also clarifies that this does not prevent the development of service agreements or individualized education programs related to PERT.

Education

https://www.palegis.us/legislation/bills/2025/hb2267